Share |

PrintPrintable version

The Cancer Drug Market Just Hit $100 Billion And Could Jump 50% In Four Years

| | Comments (1)

The global market for cancer drugs has hit $100 billion in annual sales, and could reach $147 billion by 2018, according to a new report by the IMS Institute for Healthcare Informatics, a unit of drug data provider IMS Health.

This figure does not include discounts or rebates paid to insurers and government programs; IMS says that in the case of cancer drugs, this should not make a big difference the overall figure.


“We’re sitting on the edge of an enormous amount of innovation that is really going to transform the landscape for providers, for patients, and for those companies bringing these products to market,” says Murray Aitken, executive director of the IMS Institute. Below are some highlights from the report.

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

1 Comment

As there is no drugs for the cancer, the available drugs are becoming more and more useable to reduce the pain and symtomps of the cancer.Such a great help with essay writing at which helps the students to prepare their rresearch paper for the submission.

Leave a comment

Health Supreme News

Powered by Movable Type 5.13-en

Receive updates

Subscribe to get updates of this site by email:

Enter your Email

Preview | Powered by FeedBlitz

Other sites of ours